Publicou 12 edições por ano
ISSN Imprimir: 1521-9437
ISSN On-line: 1940-4344
Indexed in
New Dietary Supplements from Medicinal Mushrooms: Dr Myko SanA Registration Report
RESUMO
In December 2010 the Ministry of Health and Social Welfare of the Republic of Croatia registered tablet preparations AGARIKON.1 and MYKOPROTECT.1, developed by Dr Myko SanHealth From Mushrooms Co., as dietary supplements. This may be the first time for a European manufacturer to successfully register its own medicinal mushroom products in a European country. As a product with a very broad spectrum of action, officially described as a preparation for immunity strengthening and general health improvement, AGARIKON.1 is a result of 20 years of research and practice, and is based on the formulation that has achieved the best tumor growth inhibition ratesabove 90% on tumor cell lines of mouse squamous cell carcinoma and fibrosarcoma.
Since the usage of massive dosages of proprietary blended liquid mushroom extracts in patients with breast, colorectal, lung, and other cancers significantly improved their survival rates, alleviated side effects of standard oncological therapies, improved their quality of life, and resulted in life prolongationthe very idea is that scientifically verified medicinal mushroom products can be used as powerful biological weapons to fight human malignancies. If progressive modern medicine were redefined in a more effective and humane way, cancer mycotherapy should be a part of a broad concept of biological prevention and therapy of cancer. Also, with a very broad spectrum of action, generally formulated as "to strengthen immunity," MYKOPROTECT.1 is intended as an important element in the prevention and fighting of serious viral infections, whether they are caused by well-known viruses (hepatitis, HIV, etc.) or newly emerging ones.
-
De Silva Dilani D., Rapior Sylvie, Hyde Kevin D., Bahkali Ali H., Medicinal mushrooms in prevention and control of diabetes mellitus, Fungal Diversity, 56, 1, 2012. Crossref
-
De Silva Dilani D., Rapior Sylvie, Fons Françoise, Bahkali Ali H., Hyde Kevin D., Medicinal mushrooms in supportive cancer therapies: an approach to anti-cancer effects and putative mechanisms of action, Fungal Diversity, 55, 1, 2012. Crossref
-
De Silva Dilani D., Rapior Sylvie, Sudarman Enge, Stadler Marc, Xu Jianchu, Aisyah Alias S., Hyde Kevin D., Bioactive metabolites from macrofungi: ethnopharmacology, biological activities and chemistry, Fungal Diversity, 62, 1, 2013. Crossref
-
Gargano Maria Letizia, van Griensven Leo J. L. D., Isikhuemhen Omoanghe S., Lindequist Ulrike, Venturella Giuseppe, Wasser Solomon P., Zervakis Georgios I., Medicinal mushrooms: Valuable biological resources of high exploitation potential, Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology, 151, 3, 2017. Crossref
-
Friedman Mendel, Mushroom Polysaccharides: Chemistry and Antiobesity, Antidiabetes, Anticancer, and Antibiotic Properties in Cells, Rodents, and Humans, Foods, 5, 4, 2016. Crossref
-
Badalyan Susanna M., Barkhudaryan Anush, Rapior Sylvie, Recent Progress in Research on the Pharmacological Potential of Mushrooms and Prospects for Their Clinical Application, in Medicinal Mushrooms, 2019. Crossref
-
Muszyńska Bożena, Fijałkowska Agata, Sułkowska‐Ziaja Katarzyna, Włodarczyk Anna, Kaczmarczyk Piotr, Nogaj Ewa, Piętka Jacek, Fomitopsis officinalis : a Species of Arboreal Mushroom with Promising Biological and Medicinal Properties , Chemistry & Biodiversity, 17, 6, 2020. Crossref
-
Jakopovic Boris, Horvatić Anita, Klobučar Marko, Gelemanović Andrea, Grbčić Petra, Oršolić Nada, Jakopovich Ivan, Kraljević Pavelić Sandra, Treatment With Medicinal Mushroom Extract Mixture Inhibits Translation and Reprograms Metabolism in Advanced Colorectal Cancer Animal Model as Evidenced by Tandem Mass Tags Proteomics Analysis, Frontiers in Pharmacology, 11, 2020. Crossref
-
Dasgupta Adhiraj, Acharya Krishnendu, Bioactive terpenoids from mushrooms, in New and Future Developments in Microbial Biotechnology and Bioengineering, 2021. Crossref
-
Jakopovic Boris, Oršolić Nada, Kraljević Pavelić Sandra, Antitumor, Immunomodulatory and Antiangiogenic Efficacy of Medicinal Mushroom Extract Mixtures in Advanced Colorectal Cancer Animal Model, Molecules, 25, 21, 2020. Crossref
-
Jakopovic Boris, Oršolić Nada, Jakopovich Ivan, Proteomic Research on the Antitumor Properties of Medicinal Mushrooms, Molecules, 26, 21, 2021. Crossref
-
Regueiro Cristina, Codesido Laura, García-Nimo Laura, Zarraquiños Sara, Remedios David, Rodríguez-Blanco Arturo, Sinde Esteban, Fernández-de-Ana Catalina, Cubiella Joaquín, Effect of the Nutraceutical Micodigest 2.0 on the Complication Rate of Colorectal Cancer Surgery With Curative Intent: Protocol for a Placebo-Controlled Double-blind Randomized Clinical Trial, JMIR Research Protocols, 11, 5, 2022. Crossref